RESEARCH-USE BIOSIMILAR ANTIBODY
Sabatolimab
Monoclonal antibody · IgG4
Sabatolimab (MBG453) is a high-affinity, humanized, IgG4 (S228P) antibody targeting TIM-3, an inhibitory receptor that regulates adaptive and innate immune responses. Sabatolimab is a potential immunosuppression agent that can target TIM-3 on immune and myeloid cells.
TARGETHAVCR2
YMonoclonal antibody
CATALOGSC-BS-196
CATALOG NUMBERSC-BS-196
MOLECULAR WEIGHTApprox. 144.675 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Sabatolimab (MBG453) is a high-affinity, humanized, IgG4 (S228P) antibody targeting TIM-3, an inhibitory receptor that regulates adaptive and innate immune responses. Sabatolimab is a potential immunosuppression agent that can target TIM-3 on immune and myeloid cells.
Sabatolimab is a recombinant research-use antibody directed against HAVCR2.